- 全部删除
 
您的购物车当前为空
NCGC00135472 (DRV1 (GPR32) agonist C2A)是具有促分解功能的人Resolvin D1受体激动剂,可在β阻滞素和 cAMP 测定中激活人溶解蛋白 D1 受体 DRV1/GPR32 受体,EC50 分别为 0.37 uM 和 0.05 uM。NCGC00135472在过表达重组DRV1的细胞中引起快速阻抗变化,刺激血清处理的酶聚糖的吞噬作用。


为众多的药物研发团队赋能,
让新药发现更简单!
NCGC00135472 (DRV1 (GPR32) agonist C2A)是具有促分解功能的人Resolvin D1受体激动剂,可在β阻滞素和 cAMP 测定中激活人溶解蛋白 D1 受体 DRV1/GPR32 受体,EC50 分别为 0.37 uM 和 0.05 uM。NCGC00135472在过表达重组DRV1的细胞中引起快速阻抗变化,刺激血清处理的酶聚糖的吞噬作用。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 2,350  | In stock | |
| 5 mg | ¥ 5,630  | In stock | |
| 10 mg | ¥ 7,790  | In stock | |
| 25 mg | ¥ 11,200  | In stock | |
| 50 mg | ¥ 13,800  | In stock | |
| 100 mg | ¥ 17,500  | In stock | |
| 500 mg | ¥ 34,800  | In stock | 
| 产品描述 | NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.NCGC00135472 induces in cells overexpressing recombinant DRV1 rapid impedance changes that stimulate phagocytosis of serum-treated zymoglycans.  | 
| 靶点活性 |  β-arrestin:0.37 μM, cAMP:0.05 μM  | 
| 体外活性 | 我们实施了小分子库的高通量筛选,识别出激活重组DRV1的化学型态,包括NCGC00135472 (C2A)。在100 nM至10 mM剂量范围内,NCGC00135472 剂量依赖性地引起CHO-DRV1中阻抗的快速变化。[1]  | 
| 别名 | NCGC-00135472, NCGC 00135472, DRV1 (GPR32) agonist C2A, C2A | 
| 分子量 | 364.35 | 
| 分子式 | C20H14F2N4O | 
| CAS No. | 862811-76-5 | 
| Smiles | CC1=C(N=C2N=CC=CN12)C1=CC(NC(=O)C2=CC=C(F)C(F)=C2)=CC=C1 | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | DMSO: 1.8 mg/mL (4.94 mM), Sonication is recommended.   | ||||||||||
溶液配制表  | |||||||||||
DMSO 
  | |||||||||||
评论内容